Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $25.12B | $22.59B | +11.16% |
Cost of Revenue | $9.05B | $8.15B | +10.99% |
Gross Profit | $16.07B | $14.44B | +11.25% |
Operating Income | $4.89B | $3.69B | +32.53% |
Net Income | $3.25B | $2.99B | +8.45% |
EPS (Basic) | $8.49 | $7.86 | +8.02% |
EPS (Diluted) | $8.40 | $7.76 | +8.25% |
R&D Expense | $1.62B | $1.47B | +10.71% |
SG&A Expense | $8.65B | $7.68B | +12.57% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $47.84B | $42.97B | +11.34% |
Current Assets | $14.76B | $14.85B | -0.62% |
Total Liabilities | $25.42B | $22.34B | +13.82% |
Current Liabilities | $7.79B | $7.62B | +2.34% |
Cash & Equivalents | $4.01B | $3.65B | +9.83% |
Long-Term Debt | $14.86B | $12.19B | +21.91% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $5.04B | $4.24B | +18.91% |
Investing Cash Flow | $-4.87B | $-3B | -62.20% |
Financing Cash Flow | $113M | $-525M | +121.52% |
Dividends Paid | $1.28B | $1.22B | +5.33% |
D&A | $1.57B | $1.43B | +10.10% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 64.0% | 63.9% | +0.06% |
Operating Margin | 19.5% | 16.3% | +3.14% |
Net Margin | 12.9% | — | — |
ROA | 6.8% | — | — |
Current Ratio | $1.893 | — | — |
SYK demonstrated strong revenue growth and improved operating margins, driven by increased sales and effective cost management.
SYK's revenue increased by 11.2% year-over-year, primarily driven by strong sales performance across key product lines.
Source: Source: 10-K Income Statement, p.1
The operating margin improved by 3.1 percentage points to 19.5%, reflecting effective cost management and operational efficiencies.
Source: Source: 10-K Income Statement, p.1
R&D expenses rose by 10.7%, indicating a continued focus on innovation and product development.
Source: Source: 10-K Income Statement, p.1
The company's long-term debt increased by 21.9%, which could impact financial flexibility and increase interest expenses.
Source: Source: 10-K Balance Sheet, p.1
Unlock 2 more detailed risk analysis
Upgrade to unlockOther companies in Health Care